Jinzong Intelligent Pharmaceutical Machinery | Empowering the High-Quality Development of the Trillion-Dollar Biopharmaceutical and Health Industry

Representatives from large backbone enterprises such as Guangzhou Pharmaceutical Group, Zhong Sheng Pharmaceutical, Livzon Pharmaceutical, Kangmei Pharmaceutical, Caizhilin Pharmaceutical, and Yifang Pharmaceutical, as well as small and medium-sized enterprises, conducted one-on-one exchanges and matchmaking. The biopharmaceutical and health industry cluster achieved upstream-downstream integration and industrial upgrading, jointly promoting the synergistic and sustainable development of the ecosystem for large, medium, and small enterprises. Guangdong Jinzong Machinery Co., Ltd. also participated with various digitalized and intelligent advanced production equipment and processes, providing innovative intelligent equipment solutions for companies involved in active pharmaceutical ingredients (APIs), pharmaceutical intermediates, biologics, and ointment production. This supports industrial upgrading, energy conservation, consumption reduction, and efficiency improvement, garnering significant attention from the industry and media.

During the conference, Zhong Fulu, General Manager of Jinzong Machinery, stated in an interview with Southern Finance and Economics Channel of Guangdong Television that after technological transformation using their advanced equipment and control systems, production capacity can be significantly increased, with very notable benefits, thereby empowering the high-quality development of the biopharmaceutical and health industry cluster.